Skip to main content

Table 1 Sample data summary of signalment, laminitis risk factor, pathology category, and ER stress/UPR marker data

From: Detection of endoplasmic reticulum stress and the unfolded protein response in naturally-occurring endocrinopathic equine laminitis

Samples (case #, limb)

Age (yr)

Breed

Sex

Laminitis Risk Factor

Laminitis Category

Immunoblot Relative Band Intensities (arbitrary units)

Grp78/BiP Localization

XBP1s

Grp78/BiP

Grp94

Control

61 RF

11

WB

MC

NL/O

SUB

26.8

15.7

12

nd

92 LF

18

WB

F

NL/O

SUB

24.7

11.4

17.1

nd

102 LF

17

QH

F

NL/O

NL

38.4

0.9

25

negative

110 LF

14

TB

MC

NL/O

NL

9.7

nd

17.2

nd

111 LF

18

TB

F

NL/O

NL

nd

nd

nd

negative

113 LF

12

TB

F

NL/O

NL

27.6

0.5

17.2

negative

114 LF

12

TB

F

NL/O

NL

5.2

2.9

26.5

negative

129 RF

22

AR

F

NL/IF

NL

5.8

18.4

42.8

negative

Mean ± sd

     

19.7 ± 12.9

8.3 ± 7.9

20.8 ± 10.7

 

EL Front Limb

63 RF

33

MO

F

PPID

SEV

79.1

12.8

17.4

nd

63 LF

33

MO

F

PPID

SEV

nd

nd

nd

AbAx

73 LF

6

TBX

F

OB/RA

MOD

36.6

20.5

13.2

negative

75 RF

22

MO

F

PPID

SEV

96.5

250

106

nd

75 LF

22

MO

F

PPID

SEV

nd

nd

nd

AbAx, Mid (KA)

90 LF

21

MH

M

OB/RA

MOD

54.3

1.9

41.5

nd

101 RF

13

MO

MC

OB/RA

SEV

16

79

91.5

AbAx, Mid (KA)

104 RF

23

WB

MC

PPID

SEV

36.6

1.3

24.5

AbAx, Mid (KA)

109 LF

9

QH

F

OB/RA

SEV

19

23.6

27.9

AbAx

116 LF

8

QH

F

OB/RA

SEV

100

131.2

100

nd

116 RF

8

QH

F

OB/RA

SEV

nd

nd

nd

AbAx, Mid (KA)

134 RF

18

TB

MC

PPID

SEV

87.3

100

57.9

negative

134 LF

18

TB

MC

PPID

SEV

nd

nd

nd

AbAx, Mid (KA)

140 LF

14

TBX

F

OB/RA

SEV

12

15.1

36.9

AbAx, Mid (KA)

141 LF

21

RMH

F

PPID

SEV

72.6

296

70.1

AbAx, Mid (KA)

141 RF

21

RMH

F

PPID

SEV

nd

nd

nd

AbAx, Mid (KA)

165 LF

23

WB

F

PPID

MOD

23

15

31.6

nd

Mean ± sd

     

52.8 ± 33.0

78.9 ± 100.2

51.5 ± 32.9

 

EL Hind Limb

63 LH

33

MO

F

PPID

SUB

nd

nd

nd

negative

73 LH

6

TBX

F

OB/RA

NL

19.4

15

39.7

negative

75 RH

22

MO

F

PPID

NL

17.8

1.7

33

negative

101 LH

13

MO

MC

OB/RA

SUB

nd

nd

nd

negative

104 RH

23

WB

MC

PPID

SUB

7.7

7.6

21.1

nd

109 RH

9

QH

F

OB/RA

NL

nd

4.7

27

negative

116 RH

8

QH

F

OB/RA

SUB

1.8

5.2

17.4

negative

134 RH

18

TB

MC

PPID

NL

3.8

33

25.4

negative

141 RH

21

RMH

F

PPID

NL

0.1

5.5

17.7

nd

165 LH

23

WB

F

PPID

NL

9.4

5.4

23.8

nd

Mean ± sd

     

8.6 ± 7.6

9.8 ± 10.2

25.7 ± 7.6

 
  1. legend: Summary of EL cases and controls used in the present study. Case numbers were assigned at the time of tissue collection, with foot identified as left front (LF), right front (RF), left hind (LH), or right hind (RH). Age listed in years. Breeds include: American Quarter Horse (QH); Arabian (AR); Miniature Horse (MH); Morgan (MO); Rocky Mountain Horse (RMH); Thoroughbred (TB); Thoroughbred cross (TBX; case 73 is TB/Clydesdale cross; case 140 is TB/WB cross); Warmblood (WB). Sex is listed as female (F), male (M), or male castrate (MC). Diagnosis includes non-laminitic, other orthopedic issues (NL/O); non-laminitic, infertility (NL/IF); PPID; obesity/regional adiposity (OB/RA). Laminitis categories include non-laminitic (NL); sub-clinical (SUB), Moderate chronic-active (MOD), and Severe chronic-active (SEV) based on the criteria presented in Table 2 and Methods. Relative immunoblot band intensities were normalized and calculated as described in methods. The mean ± standard deviation (sd) is given for each marker. EL Front Limbs differed from Controls (p = 0.007 (XBP1s), 0.03 (Grp78/BiP), 0.009 Grp94) and from EL Hind Limbs (p = 0.006 (XBP1s), 0.05 (Grp78/BiP). Anti-Grp78/BiP labeled sections were scored visually for detectable expression. Positive antibody labeling is noted by location along the PEL axis: abaxial (AbAx), middle (Mid), keratinized axis (KA). nd, not determined